Interstitial lung disease points to consider for clinical trials in systemic sclerosis

Interstitial lung disease causes major morbidity and mortality in patients with systemic sclerosis (SSc-ILD). Large randomized clinical trials in SSc-ILD have provided important information regarding the feasibility, reliability and validity of outcome measures. Forced vital capacity percentage pred...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Rheumatology (Oxford)
Hlavní autoři: Khanna, Dinesh, Seibold, James, Goldin, Jonathan, Tashkin, Donald P., Furst, Daniel E., Wells, Athol
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Reviews
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850349/
https://ncbi.nlm.nih.gov/pubmed/28992174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex203
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky